claim: moderna advances late-stage development of its vaccine against covid-19
evidence_1: 11, 2020-- moderna, inc., (nasdaq: mrna) a clinical stage biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced progress on late-stage development of mrna-1273, the companys mrna vaccine candidate against covid-19.